Integ. Thermopl. (530921)
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹5.3 |
| Market Cap | ₹5.49 Cr |
| P/E Ratio | 0 |
| ROCE | 0% |
| ROE | 6.39% |
| Dividend Yield | 0% |
| Profit Growth | 61.89% |
| Debt/Equity | — |
| Sales Growth | -93.09% |
| 52-Week Range | ₹6 — ₹9.82 |
| Sector | Industrial Products |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I have learned that a wonderful business at a fair price is better than a poor business at a cheap price. Integ. Thermopl. fails that test today. This is a plastic products company with sales down 93.09%, and the latest quarter shows sales of ₹0 crore and a net loss of ₹1 crore. Against a market capitalization of just ₹5 crore, that loss is enormous. The price of ₹5.30 is even below the 52-week range of ₹6.00 to ₹9.82; Mr. Market is not offering a bargain, he is offering a warning. Graham taught me to measure certainty through book value and earnings power. Here, book value and debt-equity are not available, ROCE is zero, and P/E is meaningless. The reported ROE of 6.39% conflicts with the latest quarterly loss, so I cannot trust the aggregate numbers. Profit growth of 61.89% is a mathematical illusion from a very low base; it does not represent a recoverable franchise. The Piotroski F-Score of 5/9 is middling, not enough to overcome the disappearance of revenue. There is no dividend, no promoter holding disclosure, and no evidence of a moat. In India’s market, micro-caps like this are often vehicles for value traps. Unless we see real orders, honest financials, and a credible path to positive earnings, this is a business I would watch from the sidelines. My job is to invest with margin of safety, not to guess at turnarounds. This is a speculative turnaround at best, and the data does not support action today.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer